RxDoctor Payments Data

Jaicharan Iyengar, MD

Orthopaedic Surgery · Stockton, CANPI 1801123690

Payments from drug & device makers

$66,402in general payments, 2019–2025

Across 52 payments — averaging $1276.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exactech, Inc.$52K
  • Linvatec Corporation$14K
  • Cornerstone Medical Associates, Inc.$766
  • Arthrex$56
  • Biotissue Holdings Inc.$35
  • Smith+Nephew$18
$73,000in research payments, 2019–2025

Across 7 payments — averaging $10,429 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Exactech, Inc.$73K

What the payments were for

  • Consulting fees$53,63186%
  • Travel & lodging$6,94911%
  • Food & beverage$1,4322%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Exactech, Inc.30$51,635
Linvatec Corporation17$13,891
Cornerstone Medical Associates, Inc.1$766
Arthrex2$56
Biotissue Holdings Inc.1$35
Smith+Nephew1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$66,402 in reported general payments places this provider in the 85th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$271,354
Medicare patients
359
Services billed
2,543

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib59$1,829
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen140$582
Ondansetron Hcl116$485
Ibuprofen111$349
Methylprednisolone48$264
Tranexamic Acid11$229
Gabapentin46$213
Meloxicam17$107
Tramadol Hcl13$21

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Stockton

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →